Cyclerion Strengthens Development of Closed-Loop Anesthetic Platform through Strategic Collaboration Agreement with Medsteer – – Comprehensive Business Update and Path to Initiating Phase 2 ...

An announcement from Xuanzhu Biopharmaceutical Co., Ltd. Class H ( ($HK:2575) ) is now available. Xuanzhu Biopharmaceutical has appointed its ...

The runaway winner among Minnesota-based public company stocks in 2025 was a company with no revenue but huge promise. Plymouth-based Celcuity, a clinical stage biopharmaceutical company, is ...

Transcenta Therapeutics, a global biopharmaceutical company with capabilities in discovery, research, development and ...

FUJIFILM Corporation today announced the completion of one of Japan’s largest bio CDMO*1 facilities (the new plant) at the ...

Dublin, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Process Analytical Technology Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering.

Ginkgo and Partners to Develop Monoclonal Antibody Biomanufacturing Innovations and to Produce an Anti-Filovirus Medical Countermeasure BOSTON, Nov. 3, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) ...

Navidea Biopharmaceuticals Inc. has filed for Chapter 11 bankruptcy under Subchapter V in the U.S. Bankruptcy Court for the District of Delaware, aiming to restructure its financial obligations while ...

The biopharmaceutical industry must navigate a complex ecosystem in which therapy innovation is linked intrinsically to stringent quality standards and regulatory mandates. Raman spectroscopy has ...